CellProthera
PrivateLast Round
VC Round
Mar 30, 2023
Total Funding Raised
$22.64M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
CellProthera is a biotechnology company that develops regenerative cell therapy for the structural and functional regeneration of cardiac lesions following a severe heart attack.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware + Subscription, Government Contracts, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellProthera Comparables
Compare CellProthera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioCardia Inc | 81% | |
| Bayer AG | 73% | |
| Vericel Corporation | 68% | |
CellProthera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 30, 2023 | ||||
| Grant | May 1, 2018 | ||||
| VC Round | Sep 3, 2014 | ||||
| Grant | Jul 11, 2013 | ||||
| Seed | Sep 1, 2009 |
Key People
Founding team and executive leadership
CellProthera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| Alsace Business Angels | VC Round, Seed |
| SODIV | VC Round |
| Bpifrance | VC Round, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 61% MoM, reaching 1K.
- Jul 20, 2026
Open roles increased to 29, 107% of current headcount.
CellProthera Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CellProthera's valuation, stock price, and market status.